Intelligent Bio Solutions Inc. SEC filings INBS

Intelligent Bio Solutions Inc. has 467 filings in SEC EDGAR's recent list, going back to Dec 29, 2017. Its latest annual report, Form ARS, was filed on Nov 2, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 13, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (bylaw or fiscal year change, regulation fd disclosure). The company's fiscal year ends on June 30.

Intelligent Bio Solutions Inc. SEC filings
Form Description Filed Period
424B3 Prospectus Sep 23, 2026 —
S-3 Shelf registration Sep 15, 2026 —
424B5 Prospectus supplement Mar 23, 2026 —
424B3 Prospectus Jan 21, 2026 —
S-3 Shelf registration Jan 9, 2026 —
S-8 Employee stock plan registration Dec 5, 2025 —
424B5 Prospectus supplement Sep 18, 2025 —
424B3 Prospectus Sep 15, 2025 —
424B3 Prospectus Sep 11, 2025 —
S-3/A Filing Aug 25, 2025 —
S-3 Shelf registration Aug 22, 2025 —
S-8 Employee stock plan registration May 30, 2025 —
S-3 Shelf registration Apr 11, 2025 —
424B5 Prospectus supplement Mar 11, 2025 —
424B5 Prospectus supplement Feb 21, 2025 —
424B5 Prospectus supplement Feb 20, 2025 —
424B5 Prospectus supplement Feb 19, 2025 —
424B5 Prospectus supplement Sep 18, 2024 —
424B3 Prospectus Mar 28, 2024 —
S-3 Shelf registration Mar 18, 2024 —
424B3 Prospectus Mar 18, 2024 —
S-3 Shelf registration Mar 4, 2024 —
S-8 Employee stock plan registration Jan 12, 2024 —
424B4 Prospectus Oct 3, 2023 —
S-1/A Amended registration statement Sep 28, 2023 —
S-1/A Amended registration statement Sep 22, 2023 —
S-1/A Amended registration statement Sep 11, 2023 —
S-1/A Amended registration statement Sep 5, 2023 —
FWP Free writing prospectus Jul 31, 2023 —
S-1/A Amended registration statement Jul 27, 2023 —
S-1 Registration statement Jul 12, 2023 —
424B3 Prospectus Jul 10, 2023 —
S-1/A Amended registration statement Jun 23, 2023 —
S-1 Registration statement Jun 6, 2023 —
S-8 Employee stock plan registration May 31, 2023 —
424B5 Prospectus supplement Mar 9, 2023 —
424B5 Prospectus supplement Mar 7, 2023 —
S-8 Employee stock plan registration Aug 5, 2022 —
S-3 Shelf registration Apr 8, 2022 —
S-1/A Amended registration statement Mar 10, 2021 —
S-1/A Amended registration statement Feb 16, 2021 —
S-1 Registration statement Jan 21, 2021 —
424B4 Prospectus Dec 28, 2020 —
S-1MEF Filing Dec 22, 2020 —
S-1/A Amended registration statement Dec 21, 2020 —
FWP Free writing prospectus Dec 8, 2020 —
S-1/A Amended registration statement Dec 8, 2020 —
S-1/A Amended registration statement Nov 16, 2020 —
S-1/A Amended registration statement Oct 20, 2020 —
S-1/A Amended registration statement Oct 13, 2020 —
FWP Free writing prospectus Oct 5, 2020 —
S-1/A Amended registration statement Oct 1, 2020 —
S-1/A Amended registration statement Aug 6, 2020 —
S-1/A Amended registration statement Nov 29, 2019 —
S-1/A Amended registration statement Sep 19, 2019 —
S-1/A Amended registration statement Aug 21, 2019 —
S-1/A Amended registration statement Aug 2, 2019 —
S-1 Registration statement Jul 5, 2019 —

Showing 58 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
INBS (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1725430
Former names
GBS Inc. (until Oct 18, 2022); Glucose Biosensor Systems (Greater China) Holdings, Inc. (until Sep 19, 2019)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.